Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "White blood cells response to pathogens" does not refer to a single molecular target, receptor, enzyme, transporter, or other discrete therapeutic target. Instead, it describes the collective actions of various types of white blood cells—also known as leukocytes—in recognizing and defending against infectious agents such as bacteria, viruses, fungi, and parasites[1][4][5]. White blood cells are produced in the bone marrow from hematopoietic stem cells and circulate throughout the body via the bloodstream and lymphatic system[5]. They include several subtypes with distinct roles: Neutrophils and macrophages perform phagocytosis by engulfing pathogens[2][5]. Lymphocytes, including B cells and T cells, mediate adaptive immunity. B lymphocytes produce antibodies that bind antigens on pathogens for neutralization or destruction. T lymphocytes directly attack infected host cells or help coordinate immune responses through cytokine release[1][3][6]. Other subtypes like eosinophils combat parasites and participate in allergic reactions; basophils release histamine during inflammatory responses[2]. The coordinated activity of these diverse leukocyte populations constitutes both innate immunity (immediate but non-specific) and adaptive immunity (delayed but highly specific)[3]. Dysregulation of these responses is implicated in diseases such as immunodeficiencies (where WBC function is impaired), autoimmune diseases (where WBCs attack self-tissues), chronic inflammation, leukemia/lymphoma (malignant proliferation), among others[2]. Because this entry refers broadly to an entire physiological process rather than a defined molecular entity suitable for direct drug targeting or biomarker development at the level expected for drug discovery databases—and because it lacks specificity—it should be flagged as incorrect for use as a canonical therapeutic target. “There are several types of white blood cells…they have different roles in defending the body against bacterial, viral…infections. When they locate an infection…these cells move to the site under attack…” [1] “White blood cells engage in constant surveillance…to identify and neutralize potential threats. This ongoing vigilance is crucial for maintaining a prompt…and effective immune response.” [2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on White blood cell response to pathogen.